1 ion capabilities (<2%), acceptable accuracy (
intra-assay 92-113%, inter-assay 69-138%) and precision
2 otypes < 0.01%), and robust reproducibility (
intra-assay:
98%; inter-assay: 97%).
3 The
intra-assay accuracy ranged from 94.0 to 104%.
4 The
intra-assay and inter-assay coefficient of variations of
5 The
intra-assay and inter-assay coefficients of variation (C
6 The
intra-assay and inter-assay coefficients of variation fo
7 The
intra-assay and inter-assay CV values of this assay were
8 The
intra-assay and inter-assay efficacy of EBC-SURE for its
9 The
intra-assay and inter-assay variation coefficients were
10 The
intra-assay and interassay coefficient of variation valu
11 Accuracy was >or=85.7% with
intra-assay and interassay imprecision<or=13.9 and 12.4%
12 We evaluated the
intra-assay and interassay reproducibility at low index
13 We introduce a robust assay with an average
intra-assay coefficient of variation (CV) of 4% and an i
14 InflammaDry showed a high inter- and
intra-assay coefficient of variation at 10 min (28.4% an
15 dynamic range between 1 and 100 mug/L and an
intra-assay coefficient of variation of 11%.
16 a detection limit of 10 viral copies with an
intra-assay coefficient of variation of 19%.
17 The inter-assay and
intra-assay coefficients of variation (CVs) were <=14.83
18 In the validation study, mean
intra-assay coefficients of variation (n=162) were 15%,
19 The method was precise (mean
intra-assay coefficients of variation [CVs], 0.8%, and m
20 rassay CVs < 3% and ICCs > 99%; urine assay,
intra-assay CV = 7.7% and ICC = 98.2% and interassay CV
21 s 12 pg/mL and 20 pg/mL respectively with an
intra-assay CV of 11.3% at the CCbeta and an average rec
22 sing conventional chromogenic IHC and showed
intra-assay heterogeneity (E1L3N coefficient of variatio
23 The coefficient of variation (CV) for
intra-assay imprecision was < 5% and inter-assay impreci
24 a less than 15% coefficient of variation for
intra-assay,
interassay, and interoperator variability.
25 The cRMP is highly precise with
intra-assay,
interassay, and total percent CVs of 2.7%,
26 Mean
intra-assay (
n = 157) coefficients of variation were 15%
27 s with known COVID-19 status, and precision (
intra-assay percent coefficient of variation; %CV) and r
28 assay demonstrated high levels of inter- and
intra-assay precision and accuracy, and the linear range
29 h specificity to detect ApoB-100, acceptable
intra-assay precision and good stability, functioning as
30 nge from 80% to 102% whereas inter-assay and
intra-assay precision are lower than 15%.
31 Inter- and
intra-assay precision had coefficients of variation of <
32 tration levels for each analyte demonstrated
intra-assay precision of < or =2.5% coefficient of varia
33 The
intra-assay precision ranged from 4.1 to 7.3% RSD.
34 Acceptable
intra-assay precision was achieved.
35 Intra-assay precision was demonstrated by performance of
36 performed on spiked specimens for linearity,
intra-assay precision, interassay precision, limit of de
37 capable of attaining the necessary level of
intra-assay precision.
38 hese assays were validated for linearity and
intra-assay precision.
39 Intra-assay repeatability was found to be between 2.5 an
40 The inter- and
intra-assay reproducibilities varied by drug, with an av
41 The coefficients of variation of the
intra-assay reproducibility and inter-assay reproducibil
42 nt samples were used to determine inter- and
intra-assay reproducibility and linearity, which were ve
43 , S/N = 3), high specificity, good inter-and
intra-assay reproducibility and satisfactory storage sta
44 Intra-assay reproducibility of this MALDI MS method was
45 All assays showed acceptable
intra-assay reproducibility; however, most were associat
46 Inter- and
intra-assay results showing relative standard deviations
47 The results were evaluated as to
intra-assay sensitivity, precision, and ability to detec
48 However, the reactions are prone to
intra-assay spatial variation in hybridization efficienc
49 To achieve this goal, the QAP required an
intra-assay standard deviation of no greater than 0.15 l
50 monstrated highly reproducible results, with
intra-assay standard deviations (measured in log(10) RNA
51 Inter- and
intra-assay studies of negative mussel samples spiked wi
52 SDs of less than 4 and 3%, respectively, for
intra-assay studies.
53 Inter- and
intra-assay variability and changes overtime were determ
54 Inter- and
intra-assay variability and electrode uniformity were fa
55 Intra-assay variability determinations using the coeffic
56 rrelation coefficient, > or = 0.88) and good
intra-assay variability in laboratory 3 (correlation coe
57 However, the
intra-assay variability in the measurement of exosome co
58 iations including interassay variability and
intra-assay variability of the assays were modest, i.e.,
59 Inter- and
intra-assay variability of the PC biosensor were both <1
60 he PC biosensor assay in terms of inter- and
intra-assay variability, spike-recovery (%), limit of de
61 quality, reproducibility, and insignificant
intra-assay variability.
62 cycle, all changes were within the range of
intra-assay variability.
63 Mean
intra-assay variances were 0.05, 0.05, and 0.06 log(10)
64 alidation parameters such as inter-assay and
intra-assay variation gave values of <5% coefficient of
65 y distributed antibody probe solution causes
intra-assay variation in background and eta.
66 e: the coefficient of variance of inter- and
intra-assay variation is between 3.9% and 9.8% for all a
67 ange of 10(8)-10(3) DPD mRNA copies, with an
intra-assay variation of <5%.